litlas
Log inCreate account

David P. Fairlie

Active 1981–2025

Also published as
David P Fairlie
195
Papers
30,150
Citations
98
h-index
190
i10-index

Citations

Citations per year for David P. Fairlie1982: 1 citations1989: 2 citations1990: 2 citations1991: 1 citations1992: 2 citations1993: 1 citations1994: 1 citations1995: 4 citations1996: 7 citations1997: 4 citations1998: 15 citations1999: 25 citations2000: 57 citations2001: 72 citations2002: 124 citations2003: 139 citations2004: 192 citations2005: 184 citations2006: 163 citations2007: 180 citations2008: 166 citations2009: 176 citations2010: 186 citations2011: 223 citations2012: 205 citations2013: 214 citations2014: 289 citations2015: 349 citations2016: 357 citations2017: 323 citations2018: 378 citations2019: 1,073 citations2020: 1,428 citations2021: 1,284 citations2022: 874 citations2023: 707 citations2024: 1,156 citations2025: 645 citations2026: 16 citations1983–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,411 citing papers, 23.2% of this breakdownChina: 1,170 citing papers, 11.3% of this breakdownAustralia: 812 citing papers, 7.8% of this breakdownUnited Kingdom: 715 citing papers, 6.9% of this breakdownGermany: 549 citing papers, 5.3% of this breakdownFrance: 366 citing papers, 3.5% of this breakdownItaly: 353 citing papers, 3.4% of this breakdownIndia: 310 citing papers, 3% of this breakdownCanada: 308 citing papers, 3% of this breakdownJapan: 265 citing papers, 2.6% of this breakdownNetherlands: 208 citing papers, 2% of this breakdownSwitzerland: 205 citing papers, 2% of this breakdown
0%23.2%Other 26%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology33.8%
  • Medicine31.8%
  • Immunology and Microbiology19.4%
  • Chemistry2.7%
  • Computer Science2.6%
  • Neuroscience2.2%
  • Other7.5%

Topics

  • Immune Cell Function and Interaction4.1%
  • Chemical Synthesis and Analysis3.9%
  • Alzheimer's disease research and treatments3.7%
  • Computational Drug Discovery Methods2.8%
  • T-cell and B-cell Immunology2.5%
  • Histone Deacetylase Inhibitors Research2.4%
  • Other80.6%

Coauthors

All papers

Open in search
  1. The Future of Peptide‐based Drugs

    Authors: David J. Craik, David P. Fairlie, Spiros Liras, David A. Price - Chemical Biology & Drug Design 2012 cited by 1,956

  2. MR1 presents microbial vitamin B metabolites to MAIT cells

    Authors: Lars Kjer‐Nielsen, Onisha Patel, Alexandra J. Corbett, Jérôme Le Nours, Bronwyn S. Meehan, Ligong Liu, Mugdha Bhati, Zhenjun Chen, Lyudmila Kostenko, Rangsima Reantragoon, Nicholas A. Williamson, Anthony W. Purcell, Nadine L. Dudek, Malcolm J. McConville, Richard A. J. O’Hair, George N. Khairallah, Dale I. Godfrey, David P. Fairlie, Jamie Rossjohn, James McCluskey - Nature 2012 cited by 1,363

  3. T-cell activation by transitory neo-antigens derived from distinct microbial pathways

    Authors: Alexandra J. Corbett, Sidonia B. G. Eckle, Richard W. Birkinshaw, Ligong Liu, Onisha Patel, Jennifer Mahony, Zhenjun Chen, Rangsima Reantragoon, Bronwyn S. Meehan, Hanwei Cao, Nicholas A. Williamson, Richard A. Strugnell, Douwe van Sinderen, Jeffrey Y. W. Mak, David P. Fairlie, Lars Kjer‐Nielsen, Jamie Rossjohn, James McCluskey - Nature 2014 cited by 903

  4. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc

    Authors: Sarah K. Madden, Aline D. de Araujo, Mara Gerhardt, David P. Fairlie, Jody M. Mason - Molecular Cancer 2021 cited by 408

  5. Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles

    Authors: Richard M. Meade, David P. Fairlie, Jody M. Mason - Molecular Neurodegeneration 2019 cited by 418

  6. Orally Absorbed Cyclic Peptides

    Authors: Daniel S. Nielsen, Nicholas E. Shepherd, Weijun Xu, Andrew J. Lucke, Martin J. Stoermer, David P. Fairlie - Chemical Reviews 2017 cited by 443

  7. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches

    Authors: David J. Brayden, Timothy A. Hill, David P. Fairlie, Sam Maher, Randall J. Mrsny - Advanced Drug Delivery Reviews 2020 cited by 245

  8. Histone deacetylases as regulators of inflammation and immunity

    Authors: Melanie R. Shakespear, Maria A. Halili, Katharine M. Irvine, David P. Fairlie, Matthew J. Sweet - Trends in Immunology 2011 cited by 542

  9. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells

    Authors: Rangsima Reantragoon, Alexandra J. Corbett, Isaac G. Sakala, Nicholas A. Gherardin, John B. Furness, Zhenjun Chen, Sidonia B. G. Eckle, Adam P. Uldrich, Richard W. Birkinshaw, Onisha Patel, Lyudmila Kostenko, Bronwyn S. Meehan, Katherine Kedzierska, Ligong Liu, David P. Fairlie, Ted H. Hansen, Dale I. Godfrey, Jamie Rossjohn, James McCluskey, Lars Kjer‐Nielsen - The Journal of Experimental Medicine 2013 cited by 598

  10. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells

    Authors: Sidonia B. G. Eckle, Richard W. Birkinshaw, Lyudmila Kostenko, Alexandra J. Corbett, Hamish E. G. McWilliam, Rangsima Reantragoon, Zhenjun Chen, Nicholas A. Gherardin, Travis Beddoe, Ligong Liu, Onisha Patel, Bronwyn S. Meehan, David P. Fairlie, Jóse A. Villadangos, Dale I. Godfrey, Lars Kjer‐Nielsen, James McCluskey, Jamie Rossjohn - The Journal of Experimental Medicine 2014 cited by 308

  11. A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage

    Authors: Hui‐Fern Koay, Nicholas A. Gherardin, Anselm Enders, Liyen Loh, Laura K. Mackay, Catarina F. Almeida, Brendan E. Russ, Claudia A. Nold‐Petry, Marcel F. Nold, Sammy Bedoui, Zhenjun Chen, Alexandra J. Corbett, Sidonia B. G. Eckle, Bronwyn S. Meehan, Yves d’Udekem, Igor E. Konstantinov, Martha Lappas, Ligong Liu, Christopher C. Goodnow, David P. Fairlie, Jamie Rossjohn, Mark M. W. Chong, Katherine Kedzierska, Stuart P. Berzins, Gabrielle T. Belz, James McCluskey, Adam P. Uldrich, Dale I. Godfrey, Daniel G. Pellicci - Nature Immunology 2016 cited by 366

  12. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers

    Authors: Azad Rahimpour, Hui‐Fern Koay, Anselm Enders, Rhiannon Clanchy, Sidonia B. G. Eckle, Bronwyn S. Meehan, Zhenjun Chen, Belinda Whittle, Ligong Liu, David P. Fairlie, Christopher C. Goodnow, James McCluskey, Jamie Rossjohn, Adam P. Uldrich, Daniel G. Pellicci, Dale I. Godfrey - The Journal of Experimental Medicine 2015 cited by 383

  13. Constraining Cyclic Peptides To Mimic Protein Structure Motifs

    Authors: Timothy A. Hill, Nicholas E. Shepherd, Frederik Diness, David P. Fairlie - Angewandte Chemie International Edition 2014 cited by 414

  14. The intracellular pathway for the presentation of vitamin B–related antigens by the antigen-presenting molecule MR1

    Authors: Hamish E. G. McWilliam, Sidonia B. G. Eckle, Alex Theodossis, Ligong Liu, Zhenjun Chen, Jacinta M. Wubben, David P. Fairlie, Richard A. Strugnell, Justine D. Mintern, James McCluskey, Jamie Rossjohn, Jóse A. Villadangos - Nature Immunology 2016 cited by 185

  15. Human blood MAIT cell subsets defined using MR1 tetramers

    Authors: Nicholas A. Gherardin, Michael N. T. Souter, Hui‐Fern Koay, Kirstie M. Mangas, Torsten Seemann, Timothy P. Stinear, Sidonia B. G. Eckle, Stuart P. Berzins, Yves d’Udekem, Igor E. Konstantinov, David P. Fairlie, David S Ritchie, Paul J. Neeson, Daniel G. Pellicci, Adam P. Uldrich, James McCluskey, Dale I. Godfrey - Immunology and Cell Biology 2018 cited by 272

  16. Sulfated bile acid is a host-derived ligand for MAIT cells

    Authors: E. Ito, Shinsuke Inuki, Yoshihiro Izumi, Masatomo Takahashi, Yuki Dambayashi, Lisa Ciacchi, Wael Awad, Ami Takeyama, Kensuke Shibata, Shotaro Mori, Jeffrey Y. W. Mak, David P. Fairlie, Takeshi Bamba, Eri Ishikawa, Masamichi Nagae, Jamie Rossjohn, Sho Yamasaki - Science Immunology 2024 cited by 67

  17. Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells

    Authors: Jeffrey Y. W. Mak, Weijun Xu, Robert C. Reid, Alexandra J. Corbett, Bronwyn S. Meehan, Huimeng Wang, Zhenjun Chen, Jamie Rossjohn, James McCluskey, Ligong Liu, David P. Fairlie - Nature Communications 2017 cited by 161

  18. Single Turn Peptide Alpha Helices with Exceptional Stability in Water

    Authors: Nicholas E. Shepherd, Huy N. Hoang, Giovanni Abbenante, David P. Fairlie - Journal of the American Chemical Society 2005 cited by 323

  19. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells

    Authors: Andrew N. Keller, Sidonia B. G. Eckle, Weijun Xu, Ligong Liu, Victoria A. Hughes, Jeffrey Y. W. Mak, Bronwyn S. Meehan, Troi Pediongco, Richard W. Birkinshaw, Zhenjun Chen, Huimeng Wang, Criselle D’Souza, Lars Kjer‐Nielsen, Nicholas A. Gherardin, Dale I. Godfrey, Lyudmila Kostenko, Alexandra J. Corbett, Anthony W. Purcell, David P. Fairlie, James McCluskey, Jamie Rossjohn - Nature Immunology 2017 cited by 236

  20. Stapling peptides using cysteine crosslinking

    Authors: David P. Fairlie, Aline D. de Araujo - Biopolymers 2016 cited by 137

  21. MAIT cells regulate NK cell-mediated tumor immunity

    Authors: Emma V. Petley, Hui‐Fern Koay, Melissa A. Henderson, Kevin Sek, Kirsten L. Todd, Simon P. Keam, Junyun Lai, Imran G. House, Jasmine Li, Magnus Zethoven, Amanda X. Y. Chen, Amanda J. Oliver, Jessica Michie, Andrew J. Freeman, Lauren Giuffrida, Jack D. Chan, Angela Pizzolla, Jeffrey Y. W. Mak, Timothy R. McCulloch, Fernando Souza-Fonseca-Guimarães, Conor J. Kearney, Rosemary Millen, Robert G. Ramsay, Nicholas D. Huntington, James McCluskey, Jane Oliaro, David P. Fairlie, Paul J. Neeson, Dale I. Godfrey, Paul A. Beavis, Phillip K. Darcy - Nature Communications 2021 cited by 104

  22. Function, structure and therapeutic potential of complement C5a receptors

    Authors: Peter N. Monk, A‐M Scola, Praveen K. Madala, David P. Fairlie - British Journal of Pharmacology 2007 cited by 397

  23. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals

    Authors: Zhenjun Chen, Huimeng Wang, Criselle D’Souza, Shicheng Sun, Lyudmila Kostenko, Sidonia B. G. Eckle, Bronwyn S. Meehan, David C. Jackson, Richard A. Strugnell, Hao Cao, Nancy Wang, David P. Fairlie, Ligong Liu, Dale I. Godfrey, Jamie Rossjohn, James McCluskey, Alexandra J. Corbett - Mucosal Immunology 2016 cited by 275

  24. The molecular basis underpinning the potency and specificity of MAIT cell antigens

    Authors: Wael Awad, Geraldine Jia Ming Ler, Weijun Xu, Andrew N. Keller, Jeffrey Y. W. Mak, Xin Yi Lim, Ligong Liu, Sidonia B. G. Eckle, Jérôme Le Nours, James McCluskey, Alexandra J. Corbett, David P. Fairlie, Jamie Rossjohn - Nature Immunology 2020 cited by 86